Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Triferic Pediatric Pharmacokinetic Protocol
Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Via Dialysate and IV to Pediatric Patients on Chronic Hemodialysis
Status: Enrolling
Updated:  12/31/1969
Nemours A. I. DuPont Hospital for Children
396
mi
from 43215
Wilmington, DE
Triferic Pediatric Pharmacokinetic Protocol
Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Via Dialysate and IV to Pediatric Patients on Chronic Hemodialysis
Status: Enrolling
Updated: 12/31/1969
Nemours A. I. DuPont Hospital for Children
396
mi
from 43215
Wilmington, DE
Click here to add this to my saved trials
Triferic Pediatric Pharmacokinetic Protocol
Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Via Dialysate and IV to Pediatric Patients on Chronic Hemodialysis
Status: Enrolling
Updated:  12/31/1969
Joe DiMagggio Children's Hospital/Memorial Regional Hospital
978
mi
from 43215
Hollywood, FL
Triferic Pediatric Pharmacokinetic Protocol
Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Via Dialysate and IV to Pediatric Patients on Chronic Hemodialysis
Status: Enrolling
Updated: 12/31/1969
Joe DiMagggio Children's Hospital/Memorial Regional Hospital
978
mi
from 43215
Hollywood, FL
Click here to add this to my saved trials
Triferic Pediatric Pharmacokinetic Protocol
Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Via Dialysate and IV to Pediatric Patients on Chronic Hemodialysis
Status: Enrolling
Updated:  12/31/1969
Jackson Memorial Hospital
992
mi
from 43215
Miami, FL
Triferic Pediatric Pharmacokinetic Protocol
Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Via Dialysate and IV to Pediatric Patients on Chronic Hemodialysis
Status: Enrolling
Updated: 12/31/1969
Jackson Memorial Hospital
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Triferic Pediatric Pharmacokinetic Protocol
Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Via Dialysate and IV to Pediatric Patients on Chronic Hemodialysis
Status: Enrolling
Updated:  12/31/1969
Cincinnati Children's Hospital Medical Center
97
mi
from 43215
Cincinnati, OH
Triferic Pediatric Pharmacokinetic Protocol
Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Via Dialysate and IV to Pediatric Patients on Chronic Hemodialysis
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center
97
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Triferic Pediatric Pharmacokinetic Protocol
Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Via Dialysate and IV to Pediatric Patients on Chronic Hemodialysis
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at San Antonio
1137
mi
from 43215
San Antonio, TX
Triferic Pediatric Pharmacokinetic Protocol
Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Via Dialysate and IV to Pediatric Patients on Chronic Hemodialysis
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at San Antonio
1137
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Triferic Pediatric Pharmacokinetic Protocol
Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Via Dialysate and IV to Pediatric Patients on Chronic Hemodialysis
Status: Enrolling
Updated:  12/31/1969
Children's Mercy Hospital
618
mi
from 43215
Kansas City, MO
Triferic Pediatric Pharmacokinetic Protocol
Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Via Dialysate and IV to Pediatric Patients on Chronic Hemodialysis
Status: Enrolling
Updated: 12/31/1969
Children's Mercy Hospital
618
mi
from 43215
Kansas City, MO
Click here to add this to my saved trials
Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap
Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap
Status: Enrolling
Updated:  12/31/1969
DaVita Clinical Research
625
mi
from 43215
Minneapolis, MN
Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap
Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap
Status: Enrolling
Updated: 12/31/1969
DaVita Clinical Research
625
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
A Study of LY3113593 in Participants With Chronic Kidney Disease
A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3113593 in Patients Receiving Hemodialysis
Status: Enrolling
Updated:  12/31/1969
Orlando Clinical Research Center
798
mi
from 43215
Orlando, FL
A Study of LY3113593 in Participants With Chronic Kidney Disease
A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3113593 in Patients Receiving Hemodialysis
Status: Enrolling
Updated: 12/31/1969
Orlando Clinical Research Center
798
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
A Study of LY3113593 in Participants With Chronic Kidney Disease
A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3113593 in Patients Receiving Hemodialysis
Status: Enrolling
Updated:  12/31/1969
Indiana University School of Medicine
166
mi
from 43215
Indianapolis, IN
A Study of LY3113593 in Participants With Chronic Kidney Disease
A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3113593 in Patients Receiving Hemodialysis
Status: Enrolling
Updated: 12/31/1969
Indiana University School of Medicine
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
A Study of LY3113593 in Participants With Chronic Kidney Disease
A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3113593 in Patients Receiving Hemodialysis
Status: Enrolling
Updated:  12/31/1969
Northwest Louisiana Nephrology
787
mi
from 43215
Shreveport, LA
A Study of LY3113593 in Participants With Chronic Kidney Disease
A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3113593 in Patients Receiving Hemodialysis
Status: Enrolling
Updated: 12/31/1969
Northwest Louisiana Nephrology
787
mi
from 43215
Shreveport, LA
Click here to add this to my saved trials
A Study of LY3113593 in Participants With Chronic Kidney Disease
A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3113593 in Patients Receiving Hemodialysis
Status: Enrolling
Updated:  12/31/1969
DaVita Clinical Research
625
mi
from 43215
Minneapolis, MN
A Study of LY3113593 in Participants With Chronic Kidney Disease
A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3113593 in Patients Receiving Hemodialysis
Status: Enrolling
Updated: 12/31/1969
DaVita Clinical Research
625
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
A Study of LY3113593 in Participants With Chronic Kidney Disease
A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3113593 in Patients Receiving Hemodialysis
Status: Enrolling
Updated:  12/31/1969
Clinical Advancement Center, PLLC
1136
mi
from 43215
San Antonio, TX
A Study of LY3113593 in Participants With Chronic Kidney Disease
A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3113593 in Patients Receiving Hemodialysis
Status: Enrolling
Updated: 12/31/1969
Clinical Advancement Center, PLLC
1136
mi
from 43215
San Antonio, TX
Click here to add this to my saved trials
Product Evaluation for the Effectiveness of the ClearGuard™ HD End Cap
Product Evaluation for the Effectiveness of the ClearGuard™ HD End Cap
Status: Enrolling
Updated:  12/31/1969
Frenova Renal Research
634
mi
from 43215
Waltham, MA
Product Evaluation for the Effectiveness of the ClearGuard™ HD End Cap
Product Evaluation for the Effectiveness of the ClearGuard™ HD End Cap
Status: Enrolling
Updated: 12/31/1969
Frenova Renal Research
634
mi
from 43215
Waltham, MA
Click here to add this to my saved trials
A Study to Assess the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine
An Open-Label, Single-Dose, Parallel-Group Study to Assess the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
993
mi
from 43215
Miami, FL
A Study to Assess the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine
An Open-Label, Single-Dose, Parallel-Group Study to Assess the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
A Study to Assess the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine
An Open-Label, Single-Dose, Parallel-Group Study to Assess the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
283
mi
from 43215
Knoxville, TN
A Study to Assess the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine
An Open-Label, Single-Dose, Parallel-Group Study to Assess the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
283
mi
from 43215
Knoxville, TN
Click here to add this to my saved trials
Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Changing Glucose Management
Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Changing Glucose Management
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
2006
mi
from 43215
Seattle, WA
Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Changing Glucose Management
Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Changing Glucose Management
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
2006
mi
from 43215
Seattle, WA
Click here to add this to my saved trials
Increasing Equity in Transplant Evaluation and Living Donor Kidney Transplantation
Increasing Equity in Transplant Evaluation and Living Donor Kidney Transplantation
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
Increasing Equity in Transplant Evaluation and Living Donor Kidney Transplantation
Increasing Equity in Transplant Evaluation and Living Donor Kidney Transplantation
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh
164
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Optimizing Cardiovascular Health and Physical Function in Hemodialysis Patients Through Volume Control and Exercise
Optimizing Cardiovascular Health and Physical Function in Hemodialysis Patients Through Volume Control and Exercise
Status: Enrolling
Updated:  12/31/1969
University of Illinois at Urbana-Champaign
274
mi
from 43215
Urbana, IL
Optimizing Cardiovascular Health and Physical Function in Hemodialysis Patients Through Volume Control and Exercise
Optimizing Cardiovascular Health and Physical Function in Hemodialysis Patients Through Volume Control and Exercise
Status: Enrolling
Updated: 12/31/1969
University of Illinois at Urbana-Champaign
274
mi
from 43215
Urbana, IL
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
Jacksonville Center for Clinical Research
673
mi
from 43215
Jacksonville, FL
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
Jacksonville Center for Clinical Research
673
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
River City Clinical Research
670
mi
from 43215
Jacksonville, FL
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
River City Clinical Research
670
mi
from 43215
Jacksonville, FL
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
Mid Michigan Cardiovascular Research
261
mi
from 43215
Midland, MI
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
Mid Michigan Cardiovascular Research
261
mi
from 43215
Midland, MI
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
Cardiac and Vascular Research Center of Northern Michigan
386
mi
from 43215
Petoskey, MI
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
Cardiac and Vascular Research Center of Northern Michigan
386
mi
from 43215
Petoskey, MI
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
Columbia University
481
mi
from 43215
New York, NY
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
Columbia University
481
mi
from 43215
New York, NY
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
Duke University
352
mi
from 43215
Durham, NC
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
Duke University
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
The Lindner Research Center, The Christ Hospital
98
mi
from 43215
Cincinnati, OH
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
The Lindner Research Center, The Christ Hospital
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
University of Florida
714
mi
from 43215
Gainesville, FL
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
University of Florida
714
mi
from 43215
Gainesville, FL
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
Advocate Christ Medical Center
275
mi
from 43215
Oak Lawn, IL
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
Advocate Christ Medical Center
275
mi
from 43215
Oak Lawn, IL
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
St. Vincent Medical Group
166
mi
from 43215
Indianapolis, IN
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
St. Vincent Medical Group
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
Suburban Hospital
323
mi
from 43215
Bethesda, MD
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
Suburban Hospital
323
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
Bryan Heart
mi
from 43215
Lincoln, NE
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
Bryan Heart
mi
from 43215
Lincoln, NE
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Foundation
138
mi
from 43215
Cleveland, OH
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation
138
mi
from 43215
Cleveland, OH
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
Ohio State University Medical Center
0
mi
from 43215
Columbus, OH
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
Ohio State University Medical Center
0
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
Baylor University
979
mi
from 43215
Dallas, TX
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
Baylor University
979
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
Aurora St. Luke's Medical Center
329
mi
from 43215
Milwaukee, WI
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
Aurora St. Luke's Medical Center
329
mi
from 43215
Milwaukee, WI
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
St. John Regional Hospital
934
mi
from 43215
Saint John,
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
St. John Regional Hospital
934
mi
from 43215
Saint John,
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
The University of Arizona Sarver Heart Center
1639
mi
from 43215
Tucson, AZ
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
The University of Arizona Sarver Heart Center
1639
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
Indiana/Ohio Heart
138
mi
from 43215
Fort Wayne, IN
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
Indiana/Ohio Heart
138
mi
from 43215
Fort Wayne, IN
Click here to add this to my saved trials
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated:  12/31/1969
Washington University
398
mi
from 43215
Saint Louis, MO
A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery
A Randomized, Double-Blind, Placebo Controlled , Phase 2 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI Following Cardiac Surgery
Status: Enrolling
Updated: 12/31/1969
Washington University
398
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
A Phase 1 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte Diseases
A Phase 1 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte Diseases
Status: Enrolling
Updated:  12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
A Phase 1 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte Diseases
A Phase 1 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte Diseases
Status: Enrolling
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
322
mi
from 43215
Bethesda, MD
Click here to add this to my saved trials
Study to Evaluate Sotagliflozin in Subjects With Varying Degrees of Renal Function
A Phase 1, Open-label, Parallel-group Study to Evaluate Sotagliflozin Safety and Pharmacokinetics in Subjects With Varying Degrees of Renal Function
Status: Enrolling
Updated:  12/31/1969
Lexicon Investigational Site
993
mi
from 43215
Miami, FL
Study to Evaluate Sotagliflozin in Subjects With Varying Degrees of Renal Function
A Phase 1, Open-label, Parallel-group Study to Evaluate Sotagliflozin Safety and Pharmacokinetics in Subjects With Varying Degrees of Renal Function
Status: Enrolling
Updated: 12/31/1969
Lexicon Investigational Site
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Study to Evaluate Sotagliflozin in Subjects With Varying Degrees of Renal Function
A Phase 1, Open-label, Parallel-group Study to Evaluate Sotagliflozin Safety and Pharmacokinetics in Subjects With Varying Degrees of Renal Function
Status: Enrolling
Updated:  12/31/1969
Lexicon Investigational Site
797
mi
from 43215
Orlando, FL
Study to Evaluate Sotagliflozin in Subjects With Varying Degrees of Renal Function
A Phase 1, Open-label, Parallel-group Study to Evaluate Sotagliflozin Safety and Pharmacokinetics in Subjects With Varying Degrees of Renal Function
Status: Enrolling
Updated: 12/31/1969
Lexicon Investigational Site
797
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Study to Evaluate Sotagliflozin in Subjects With Varying Degrees of Renal Function
A Phase 1, Open-label, Parallel-group Study to Evaluate Sotagliflozin Safety and Pharmacokinetics in Subjects With Varying Degrees of Renal Function
Status: Enrolling
Updated:  12/31/1969
Lexicon Investigational Site
624
mi
from 43215
Minneapolis, MN
Study to Evaluate Sotagliflozin in Subjects With Varying Degrees of Renal Function
A Phase 1, Open-label, Parallel-group Study to Evaluate Sotagliflozin Safety and Pharmacokinetics in Subjects With Varying Degrees of Renal Function
Status: Enrolling
Updated: 12/31/1969
Lexicon Investigational Site
624
mi
from 43215
Minneapolis, MN
Click here to add this to my saved trials
Study to Evaluate Sotagliflozin in Subjects With Varying Degrees of Renal Function
A Phase 1, Open-label, Parallel-group Study to Evaluate Sotagliflozin Safety and Pharmacokinetics in Subjects With Varying Degrees of Renal Function
Status: Enrolling
Updated:  12/31/1969
Lexicon Investigational Site
617
mi
from 43215
Saint Paul, MN
Study to Evaluate Sotagliflozin in Subjects With Varying Degrees of Renal Function
A Phase 1, Open-label, Parallel-group Study to Evaluate Sotagliflozin Safety and Pharmacokinetics in Subjects With Varying Degrees of Renal Function
Status: Enrolling
Updated: 12/31/1969
Lexicon Investigational Site
617
mi
from 43215
Saint Paul, MN
Click here to add this to my saved trials
Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal Impairment
An Open-Label, Multiple Ascending Dose (MAD) Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects With a Separate Panel in Subjects With Mild to Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Research by Design
272
mi
from 43215
Evergreen Park, IL
Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects and Subjects With Renal Impairment
An Open-Label, Multiple Ascending Dose (MAD) Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KBP-5074 in Healthy Subjects With a Separate Panel in Subjects With Mild to Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Research by Design
272
mi
from 43215
Evergreen Park, IL
Click here to add this to my saved trials
Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease
Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
University of Maryland Medical Center
343
mi
from 43215
Baltimore, MD
Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease
Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
University of Maryland Medical Center
343
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease
Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Tufts Medical Center
642
mi
from 43215
Boston, MA
Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease
Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
642
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Safety Study of Cenderitide in Chronic Stable Heart Failure With Moderate Renal Impairment
A Randomized, Double Blind, Placebo-Controlled, Dose Escalating, Cross Over Designed Study to Assess the Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of Open-Label, Continuous Subcutaneous Infusion of Cenderitide Via the Insulet Drug Delivery System in Chronic Stable Heart Failure Subjects With Moderate Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Orange County Research Center
1957
mi
from 43215
Tustin, CA
Safety Study of Cenderitide in Chronic Stable Heart Failure With Moderate Renal Impairment
A Randomized, Double Blind, Placebo-Controlled, Dose Escalating, Cross Over Designed Study to Assess the Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of Open-Label, Continuous Subcutaneous Infusion of Cenderitide Via the Insulet Drug Delivery System in Chronic Stable Heart Failure Subjects With Moderate Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Orange County Research Center
1957
mi
from 43215
Tustin, CA
Click here to add this to my saved trials
Pediatric Acute Kidney Injury (AKI) Retrospective, Real-Time and Repository Research
Pediatric Acute Kidney Injury (AKI) Retrospective, Real-Time and Repository Research
Status: Enrolling
Updated:  12/31/1969
Monroe Carell Jr. Children's Hospital at Vanderbilt
331
mi
from 43215
Nashville, TN
Pediatric Acute Kidney Injury (AKI) Retrospective, Real-Time and Repository Research
Pediatric Acute Kidney Injury (AKI) Retrospective, Real-Time and Repository Research
Status: Enrolling
Updated: 12/31/1969
Monroe Carell Jr. Children's Hospital at Vanderbilt
331
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Fluid Chloride and AKI in Cardiopulmonary Bypass
The Impact of Low Chloride Containing Fluids on Acute Kidney Injury After Cardiopulmonary Bypass as Assayed by Urinary [TIMP2*IGFBP7]
Status: Enrolling
Updated:  12/31/1969
The University of New Mexico Hospital
1331
mi
from 43215
Albuquerque, NM
Fluid Chloride and AKI in Cardiopulmonary Bypass
The Impact of Low Chloride Containing Fluids on Acute Kidney Injury After Cardiopulmonary Bypass as Assayed by Urinary [TIMP2*IGFBP7]
Status: Enrolling
Updated: 12/31/1969
The University of New Mexico Hospital
1331
mi
from 43215
Albuquerque, NM
Click here to add this to my saved trials